Dr. Deanna C. Menapace, MD

Dr. Menapace practices at Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic.

Dr. Menapace's NPI, 1891180048, was assigned on April 4, 2015. Dr. Menapace graduated from Creighton University School of Medicine - Omaha in 2015. Dr. Menapace holds Florida license ME160592.

Dr. Menapace's primary practice is Mayo Clinic Hospital, at 4500 San Pablo Rd, Jacksonville, FL 32224 in Duval County. The practice phone is (904) 953-2000.

Dr. Menapace's primary practice is Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic. The medical group on file is Mayo Clinic Jacksonville.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Menapace practices. Vendor and product names are available with a free account.

Otolaryngology is Dr. Menapace's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Menapace is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Menapace's licenses on file in 3 states: Florida, Minnesota and Nebraska.

Dmand AI lists acute sinusitis among the conditions Dr. Menapace treats.

CMS data shows 127 Medicare services from Dr. Menapace across 4 procedure codes in 2024, for 102 Medicare patients. Medicare paid $14,282 for them.

CMS counts 102 Medicare patients who saw Dr. Menapace in 2024. The largest group is 65 to 74, with 48 patients. 75% of them have high cholesterol, and 73% have high blood pressure. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Menapace's median patient age at 59, with 56% women.

In 2024, Dr. Menapace wrote 167 Medicare Part D claims for 56 patients. 95% of them were for generic drugs. CMS names the drug for 63 of them, across 4 drugs with 11 or more claims each, at $285 in total drug cost. In 2022, CMS named 24 claims across 1 drug.

Dr. Menapace accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Menapace as offering telehealth. CMS counts 13 procedures of melanoma (skin cancer) excision by Dr. Menapace, more than 67% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 15 papers to Dr. Menapace, published from 2016 to 2023. 2017 was the busiest year, with 3. The most frequent topics are Plastic Surgery Procedures, Postoperative Complications and Laryngostenosis. Dr. Menapace has published most often in Facial Plast Surg. Dr. Menapace's most frequent co-authors are Grant S. Hamilton, MD, Eric Scott Edell, MD and Dale Ekbom, MD.

CMS Open Payments shows 12 general payments to Dr. Menapace from 9 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Galderma Laboratories, L.P. paid the most, $85.

Dmand AI lists 16 awards for Dr. Menapace, most recently Skull Award (Highest Interdept. Board Score) in 2019. Dr. Menapace serves on AAFPRS Emerging Trends Committee, AAFPRS QI & Patient Safety Committee and AAFPRS Fellowship Curriculum Subcommittee.

Dr. Menapace graduated from Creighton University School of Medicine - Omaha in 2015. Dr. Menapace is a member of AOA, Alpha Sigma Nu, AAFPRS and NHS.

Dr. Menapace is in network with 11 carriers, including Aetna, Cigna and United Healthcare. PPO plans come from the most carriers, 5. Check the plan with the practice before a visit.